Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: An in vivo SPECT study-Reference-Cited by-同舟云学术

Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: An in vivo SPECT study

Published:2011-07 Issue:2-3 Volume:129 Page:169-171
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Safont Gemma,Corripio Iluminada,Escartí María J.,Portella Maria J.,Pérez Víctor,Ferrer Marc,Camacho Valle,Sauras Rosa B.,Alonso Anna,Grasa Eva M.,Arranz Belén,San Luis,Dueñas Rosa,Carrió Ignasi,Álvarez Enric

Funder

Fundació La Marató de TV3 clinical trial

CIBERSAM

Spanish Health Ministry

Instituto Carlos III

Lilly Pharmaceuticals

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference18 articles.

1. Causal association between cannabis and psychosis: examination of the evidence;Arseneault;Br. J. Psychiatry,2004

2. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study);Baeza;Schizophr. Res.,2009

3. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum;Bossong;Neuropsychopharmacology,2009

4. Elevated plasma dopamine metabolites in cannabis psychosis;Bowers;Am. J. Psychiatry,2007

5. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats;Cheer;J. Neurosci.,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulatory effects of cannabinoids on brain neurotransmission;European Journal of Neuroscience;2019-04-08

2. Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction;Reviews in the Neurosciences;2018-10-01

3. Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders;Journal of Psychopharmacology;2018-03-29

4. Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date;European Neuropsychopharmacology;2015-08

5. The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability;Frontiers in Psychiatry;2014-11-18